Adverse pregnancy outcomes with assisted reproductive technology in non-obese women with polycystic ovary syndrome: a case-control study

Han, Ae-Ra; Kim, Hye-Ok; Cha, Sun-Wha; Park, Chan-Woo; Kim, Jin-Yeong; Yang, Kwang-Moon; Song, In-Ok; Koong, Mi-Kyoung; Kan, Inn-Soo

추천

검색

자료유형: 학술저널

저자정보: Han, Ae-Ra (Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Cheil General Hospital, Kwandong University College of Medicine) Kim, Hye-Ok (Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Cheil General Hospital, Kwandong University College of Medicine) Cha, Sun-Wha (Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Cheil General Hospital, Kwandong University College of Medicine) Park, Chan-Woo (Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Cheil General Hospital, Kwandong University College of Medicine) Kim, Jin-Yeong (Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Cheil General Hospital, Kwandong University College of Medicine) Yang, Kwang-Moon (Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Cheil General Hospital, Kwandong University College of Medicine) Song, In-Ok (Division of Reproducti) Koong, Mi-Kyoung Kan, Inn-Soo

저널정보: 대한생식의학회 Clinical and experimental reproductive medicine : CERM Clinical and experimental reproductive medicine : CERM 제38권 제2호

발행연도: 2011.1

수록면: 103 - 108 (6page)

이용수

📌

연구주제

📖

연구배경

🔬

연구방법

🏆

연구결과

초록· 키워드

오류제보하기

Objective: To investigate adverse pregnancy outcomes in non-obese women with polycystic ovary syndrome (PCOS) compared with obese-PCOS and control groups. Methods: Women with PCOS who underwent assisted reproductive technology (ART) from August, 2003 to December, 2007, were considered. A total of 336 women with PCOS were included in the study group and 1,003 infertile women who had tubal factor as an indication for ART were collected as controls. They were divided into four groups: a non-obese PCOS group, obese-PCOS group, non-obese tubal factor group, and obese tubal factor group, with obesity defined by a body mass index over 25 kg/$m^2$, and reviewed focusing on the basal characteristics, ART outcomes, and adverse pregnancy outcomes. Results: There was no difference among the groups' the clinical pregnancy rate or live birth rate. Regarding adverse pregnancy outcomes, the miscarriage rate, multiple pregnancy rate, and prevalence of preterm delivery and pregnancy induced hypertension were not different among the four groups. The incidence of small for gestational age infant was higher in the PCOS groups than the tubal factor groups ($p$ <0.02). On the other hand, the morbidity of gestational diabetes mellitus (GDM) was not high in the non-obese PCOS group but was in the obese groups. And in the obese PCOS group, the newborns were heavier than in the other groups ($p$ <0.02). Conclusion: Non-obese PCOS presents many differences compared with obese PCOS, not only in the IVF-parameters but also in the morbidity of adverse pregnancy outcomes, especially in GDM and fetal macrosomia.

#Pregnancy Outcome #Polycystic Ovary Syndrome #Non-obese #Reproductive Techniques #Assisted #Diabetes #Gestational #Fetal Macrosomia #Human

참고문헌 (20)

참고문헌 신청

Garruti G / 2009 / Adipose tissue, metabolic syndrome and polycystic ovary syndrome: from pathophysiology to treatment / Reprod Biomed Online 19:552~563

Stout DL / 2005 / Thiazolidinediones for treatment of polycystic ovary syndrome / Pharmacotherapy 25:244~252

2009 / ACOG Committee on Practice Bulletins-Gynecology. ACOG Practice Bulletin No. 108: Polycystic ovary syndrome / Obstet Gynecol 114:936~949

전균호 / 201006 / Effects of pioglitazone on ovarian stromal blood flow, ovarian stimulation, and in vitro fertilization outcome in patients with polycystic ovary syndrome / FERTILITY AND STERILITY 94(1):236~241

Vural P / 2010 / Tumor necrosis factor alpha (-308), interleukin-6 (-174) and interleukin-10 (-1082) gene polymorphisms in polycystic ovary syndrome / Eur J Obstet Gynecol Reprod Biol 150:61~65